Literature DB >> 19643996

SPRED1 disorder and predisposition to leukemia in children.

Eric Pasmant, Paola Ballerini, Helene Lapillonne, Christine Perot, Dominique Vidaud, Guy Leverger, Judith Landman-Parker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19643996     DOI: 10.1182/blood-2009-04-218503

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  The NF1 gene in tumor syndromes and melanoma.

Authors:  Maija Kiuru; Klaus J Busam
Journal:  Lab Invest       Date:  2017-01-09       Impact factor: 5.662

2.  Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011.

Authors:  L Olsson; A Castor; M Behrendtz; A Biloglav; E Forestier; K Paulsson; B Johansson
Journal:  Leukemia       Date:  2013-07-04       Impact factor: 11.528

3.  Neurofibromatosis type 1 (NF1) associated with tumor of the corpus callosum.

Authors:  Ignacio Pascual-Castroviejo; Samuel-Ignacio Pascual-Pascual
Journal:  Childs Nerv Syst       Date:  2012-09-22       Impact factor: 1.475

4.  Overexpression and knockout of miR-126 both promote leukemogenesis.

Authors:  Zejuan Li; Ping Chen; Rui Su; Yuanyuan Li; Chao Hu; Yungui Wang; Stephen Arnovitz; Miao He; Sandeep Gurbuxani; Zhixiang Zuo; Abdel G Elkahloun; Shenglai Li; Hengyou Weng; Hao Huang; Mary Beth Neilly; Shusheng Wang; Eric N Olson; Richard A Larson; Michelle M Le Beau; Jiwang Zhang; Xi Jiang; Minjie Wei; Jie Jin; Paul P Liu; Jianjun Chen
Journal:  Blood       Date:  2015-09-11       Impact factor: 22.113

5.  Legius syndrome in fourteen families.

Authors:  Ellen Denayer; Magdalena Chmara; Hilde Brems; Anneke Maat Kievit; Yolande van Bever; Ans M W Van den Ouweland; Rick Van Minkelen; Arja de Goede-Bolder; Rianne Oostenbrink; Phillis Lakeman; Eline Beert; Takuma Ishizaki; Tomoaki Mori; Kathelijn Keymolen; Jenneke Van den Ende; Elisabeth Mangold; Sirkku Peltonen; Glen Brice; Julia Rankin; Karin Y Van Spaendonck-Zwarts; Akihiko Yoshimura; Eric Legius
Journal:  Hum Mutat       Date:  2011-01       Impact factor: 4.878

6.  Spred1 deficit promotes treatment resistance and transformation of chronic phase CML.

Authors:  Junjing Qiao; Chen Liang; Dandan Zhao; Le Xuan Truong Nguyen; Fang Chen; Shanshan Suo; Dinh Hoa Hoang; Francesca Pellicano; Ivan Rodriguez Rodriguez; Yasmin Elhajmoussa; Lucy Ghoda; Akihiko Yoshimura; Anthony S Stein; Haris Ali; Paul Koller; Danilo Perrotti; Mhairi Copland; Anjia Han; Bin Amber Zhang; Guido Marcucci
Journal:  Leukemia       Date:  2021-09-25       Impact factor: 12.883

7.  RAS MAPK inhibitors deregulation in leukemia.

Authors:  Eric Pasmant; Dominique Vidaud; Paola Ballerini
Journal:  Oncoscience       Date:  2015-12-04

Review 8.  SPRED proteins and their roles in signal transduction, development, and malignancy.

Authors:  Claire Lorenzo; Frank McCormick
Journal:  Genes Dev       Date:  2020-11-01       Impact factor: 11.361

9.  Legius Syndrome and its Relationship with Neurofibromatosis Type 1.

Authors:  Ellen Denayer; Eric Legius
Journal:  Acta Derm Venereol       Date:  2020-03-25       Impact factor: 3.875

Review 10.  Molecular screening strategies for NF1-like syndromes with café-au-lait macules (Review).

Authors:  Jia Zhang; Ming Li; Zhirong Yao
Journal:  Mol Med Rep       Date:  2016-09-22       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.